Pretzel Therapeutics
USEntry
2022
Hold
4yr
Status
Active
Who owns Pretzel Therapeutics?
Pretzel Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2022. Across its history, Pretzel Therapeutics has been through 5 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-06-21
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
5 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Angelini Ventures, GU Ventures, Eir Ventures, HealthCap and Cambridge Innovation Capital since 2021.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Active
Co-held by Angelini Ventures, GU Ventures, Eir Ventures, HealthCap and Cambridge Innovation Capital since 2021.
Co-invest · 5 holders · 2021 · present
Angelini VenturesActive
2021 · present(5yr) · Angelini Ventures · 2022 · Life Sciences VC
HealthCapActive
2022 · present(4yr) · HealthCap VIII · 2021 · VC
Eir VenturesActive
2022 · present(4yr) · Eir Ventures I · 2020 · Life Sciences VC
GU VenturesActive
2022 · present(4yr) · GU Ventures Evergreen · 1995 · VC
More from CIC Fund II
Other portfolio companies in the same fund.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Pretzel Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Pretzel Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Pretzel Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue